Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8215.29 | 1445 / 1445 | 100% | 59.87 | 183 / 183 |
liver | 100% | 6234.08 | 226 / 226 | 100% | 43.44 | 406 / 406 |
ovary | 100% | 10756.97 | 180 / 180 | 100% | 68.45 | 430 / 430 |
pancreas | 100% | 6007.02 | 328 / 328 | 100% | 69.53 | 178 / 178 |
prostate | 100% | 11415.16 | 245 / 245 | 100% | 72.57 | 502 / 502 |
skin | 100% | 9201.23 | 1809 / 1809 | 100% | 84.88 | 472 / 472 |
stomach | 100% | 7417.50 | 359 / 359 | 100% | 56.82 | 286 / 286 |
thymus | 100% | 11709.86 | 653 / 653 | 100% | 78.33 | 605 / 605 |
uterus | 100% | 9696.96 | 170 / 170 | 100% | 77.94 | 459 / 459 |
brain | 100% | 9472.83 | 2641 / 2642 | 100% | 79.65 | 705 / 705 |
lung | 100% | 9085.31 | 578 / 578 | 100% | 71.89 | 1154 / 1155 |
breast | 100% | 8591.71 | 459 / 459 | 100% | 67.14 | 1114 / 1118 |
intestine | 100% | 9238.30 | 966 / 966 | 100% | 60.14 | 525 / 527 |
bladder | 100% | 8885.57 | 21 / 21 | 99% | 64.77 | 501 / 504 |
kidney | 100% | 7959.22 | 89 / 89 | 99% | 49.97 | 895 / 901 |
adrenal gland | 100% | 8982.14 | 258 / 258 | 99% | 57.84 | 228 / 230 |
adipose | 100% | 7903.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9607.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 75.62 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 89.73 | 29 / 29 |
muscle | 100% | 8272.14 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 10291.38 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 64.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.02 | 1 / 1 |
heart | 98% | 5454.68 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 6704.28 | 909 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
GO_0034243 | Biological process | regulation of transcription elongation by RNA polymerase II |
GO_0032785 | Biological process | negative regulation of DNA-templated transcription, elongation |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_0032786 | Biological process | positive regulation of DNA-templated transcription, elongation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0140673 | Biological process | transcription elongation-coupled chromatin remodeling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0032044 | Cellular component | DSIF complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SUPT5H |
Protein name | Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (Transcription elongation factor spt5) SPT5 homolog, DSIF elongation factor subunit Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein) Alternative protein SUPT5H |
Synonyms | SPT5 SPT5H hCG_43350 |
Description | FUNCTION: Component of the DRB sensitivity-inducing factor complex (DSIF complex), which regulates mRNA processing and transcription elongation by RNA polymerase II. DSIF positively regulates mRNA capping by stimulating the mRNA guanylyltransferase activity of RNGTT/CAP1A. DSIF also acts cooperatively with the negative elongation factor complex (NELF complex) to enhance transcriptional pausing at sites proximal to the promoter. Transcriptional pausing may facilitate the assembly of an elongation competent RNA polymerase II complex. DSIF and NELF promote pausing by inhibition of the transcription elongation factor TFIIS/S-II. TFIIS/S-II binds to RNA polymerase II at transcription pause sites and stimulates the weak intrinsic nuclease activity of the enzyme. Cleavage of blocked transcripts by RNA polymerase II promotes the resumption of transcription from the new 3' terminus and may allow repeated attempts at transcription through natural pause sites. DSIF can also positively regulate transcriptional elongation and is required for the efficient activation of transcriptional elongation by the HIV-1 nuclear transcriptional activator, Tat. DSIF acts to suppress transcriptional pausing in transcripts derived from the HIV-1 LTR and blocks premature release of HIV-1 transcripts at terminator sequences. . |
Accessions | ENST00000402194.6 [O00267-2] ENST00000594990.5 ENST00000601515.5 L8E7T7 M0QYL9 ENST00000359191.10 [O00267-2] O00267 ENST00000432763.7 [O00267-1] B4E0Q4 ENST00000593727.1 M0R2M5 M0R105 ENST00000598725.5 [O00267-1] ENST00000594729.5 ENST00000599117.5 [O00267-1] |